Accrol Group Holdings LTC Acquisition immediately earnings enhancing with ongoing growth (Analyst Interview)

Accrol Group Holdings plc (LON:ACRL) is the topic of conversation when Mike Allen, Head of Research at Zeus Capital joins DirectorsTalk. Mike shares his thoughts on the LTC acquisition, how this factors into the forecasts and the key benefits of the deal.

Following the announcement made by the Company on the 23 November 2020 titled “Admission of Shares & Total Voting Rights”, Accrol Group Holdings plc, a leading independent tissue converter in the UK, has now announced that the Final Condition has now been satisfied and the Acquisition has now completed.

The capitalised terms used in this announcement have the same meanings as in the Announcement, unless otherwise stated.

Dan Wright, Executive Chairman of Accrol, said:

“We are delighted to announce the completion of this, our first acquisition. LTC fulfils all our selective M&A criteria. It’s well-invested; it’s ideally located, in central England; it has strong day-to-day management team; and its product mix and customer base are highly complementary to our existing business.

“The acquisition is immediately earnings enhancing and takes our share of the £1.7bn UK tissue market to c.16%. Importantly, it represents another milestone on our journey to build a world-class, operationally efficient business of size and scale, which delivers substantial returns to shareholders through organic and acquisitive growth. I would like to thank our existing and new shareholders for their support and confidence in our team and look forward to updating everyone on the progress of the integration in due course.

“On behalf of the team at Accrol, I welcome everyone at LTC to the Group and look forward to an exciting future working together.”

Click to view all articles for the EPIC: ,
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Accrol Group Holdings plc

More articles like this

Accrol Group

Accrol Group returns to profit

Accrol Group, the Blackburn-based AIM-listed tissue and toilet roll maker, has achieved a return to profit, despite a dip in revenues, for its interim period of trading. In the six months to October 31, 2023, the

Accrol Group

Manufacturers say UK becoming more competitive as global hub

Despite challenges such as high energy costs and political instability, Britain’s largest manufacturers see the UK as a growing global manufacturing hub. A recent survey revealed increased confidence in the sector’s prospects. Accrol Group Holdings plc is a leading UK tissue converter, contributing to the £1.6bn soft tissue market.

Accrol Group

Manufacturing outlook for 2024

Britain’s manufacturers have seen output surge by three times faster than orders in the last quarter, to +10% from a negative balance in Q3 of -3%. Such an increase is an extremely rare occurrence and potentially

Accrol Group

Is UK manufacturing going from strength to strength?

We’ve all heard the opinion banded about in the context of UK manufacturing: “We don’t make anything here any more”. But according to a recent report from Make UK, in 2021 (the most recently available data)

Accrol Group

Manufacturing output stabilises in Q4

Manufacturers reported that output volumes were stable during the final three months of the year – the first time output hasn’t fallen since the quarter to July 2023, according to the CBI’s latest Industrial Trends Survey

Accrol Group

UK factory downturn shows more signs of easing

Britain’s manufacturing sector showed further signs that it might be turning a corner in its long-running downturn but companies remained cautious and pushed up their prices, according to a survey published on Friday. The final reading

Accrol Group

Key manufacturing trends to look out for in 2024

Technological advancements, climate change, and geopolitical tensions have transformed the global manufacturing landscape in recent decades. Along the way, academics and industry experts have explored concepts such as Industry 4.0 which encompasses the industrial internet of